prespecified

Related by string. * * prespecified secondary . prespecified criteria *

Related by context. Frequent words. (Click for all words.) 68 primary efficacy endpoint 67 secondary endpoint 66 composite endpoint 66 evaluable 65 primary endpoint 64 secondary endpoints 63 efficacy endpoints 62 Secondary endpoints included 62 unfractionated heparin 62 primary endpoints 62 reach statistical significance 61 Secondary endpoints 61 non inferiority 61 Secondary endpoints include 61 clinical endpoints 61 unblinded 60 HbA1c levels 60 dose escalation 60 pharmacodynamic 60 LVEF 60 nonresponders 59 thromboembolic events 59 randomization 59 achieve statistical significance 58 insulin glargine 58 n = 58 histologic 58 statistical significance 58 mg dose 58 randomized 58 RCTs 58 placebo p 58 free survival PFS 58 peginterferon 58 sunitinib 58 ACR# [002] 57 adjuvant therapy 57 antiplatelet therapy 57 SAEs 57 statistically significant p 57 clinically meaningful 57 nonsignificant 57 placebo p = 57 evaluable patients 57 echocardiographic 57 sirolimus 57 treatment emergent adverse 57 bivalirudin 57 clinically relevant 57 myocardial ischemia 56 clopidogrel 56 sustained virologic response 56 mcg kg 56 liver metastases 56 adalimumab 56 eGFR 56 LMWH 56 P = .# 56 antithrombotic 56 glomerular filtration rate 56 placebo 56 placebo controlled trials 56 tumor recurrence 56 discontinuations 56 thromboembolism 55 preoperatively 55 ticagrelor 55 post hoc 55 HCV RNA 55 DSMB 55 elagolix 55 resected 55 revascularization 55 laboratory abnormalities 55 pioglitazone 55 g dL 55 TIMI 55 cardiovascular morbidity 55 monotherapy 55 FEV1 55 placebo controlled 55 azacitidine 55 p = #.# [002] 55 statistically significant 55 demonstrated statistically significant 55 reperfusion 55 limiting toxicity 55 RECIST 55 infliximab 55 confidence interval CI 55 myocardial infarction MI 55 target lesion revascularization 55 amlodipine 55 enoxaparin 55 median PFS 55 mg BID 54 mg d 54 FOLFOX 54 statistically significant differences 54 statistically significant improvement 54 glimepiride

Back to home page